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Abstract
Background
Approximately two thirds of patients with lumbar spinal stenosis (LSS) who undergo surgical
treatment benefit from the surgery. The objective of this study was to derive a prognostic
probability function (PPF) to identify patients with a high probability of post-surgical improve-
ment because there is currently no method available.
Methods
In this multicenter, prospective, observational study, we collected data from eight medical
centers in Switzerland in which patients underwent surgery for LSS. The endpoints were
meaningful clinically important differences (MCID) in pain and disability one year after base-
line. We developed a PPF named PROCESS (PostopeRative OutComE Spinal Stenosis),
based on a large set of prognostic indicators extracted from the literature. The PPF was
derived using data from a random subset of two thirds of the patients and validated in the
remaining third. We addressed overfitting by shrinking the regression coefficients. The area
under the ROC curve (AUC) and calibration determined the accuracy of the PPF.
Results
In this study, 452 LSS patients received surgery. 73% of the 300 patients in the derivation
subset reached an MCID in pain and 68% reached an MCID in disability. The corresponding
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values were 70% and 63% in the validation subset, respectively. In the derivation subsam-
ple, the AUC was 0.64 (95% CI 0.57 to 0.71) for of the PPF predicting MCID in pain and 0.71
(0.64 to 0.77) for MCID in disability, after shrinkage. The corresponding numbers were 0.62
(0.52 to 0.72) and 0.70 (0.60 to 0.79) in the validation subsample, and the PPF showed
good calibration.
Conclusions
Surgical treatment for patients with lumbar spinal stenosis is being performed with increas-
ing frequency. PROCESS is conditional on the individual pattern of preoperatively available
prognostic indicators, and may be helpful for clinicians in counselling patients and in guiding
the discussion on individual treatment decision in the era of personalized medicine.
Introduction
Decompression surgery is a treatment option for patients with lumbar spinal stenosis. Surgical
treatment is recommended for patients with moderate or severe clinical manifestations and no
meaningful improvement following conservative treatment, such as physiotherapy and/or epi-
dural steroid injections. Surveys among surgeons using standardized clinical cases revealed a
lack of consensus among clinical experts on the indications for surgery [1], and the wide varia-
tion in surgical rates among hospital referral regions in the USA may be explained by this lack
of consensus [2].
There is broad agreement that decompressive surgery offers an advantage for about two
thirds of patients within the first four years after surgery compared to non-surgical treatment
[3–6], while one third of patients report no meaningful improvement after surgery [4, 5]. This
difference in outcome declines between surgical and non-surgical treatment five to ten years
after surgery [7–9]. A tool for identifying patients with a high probability of post-surgical
improvement would be valuable for patients and physicians in decision-making regarding sur-
gery, and could reduce the rate of unnecessary operations.
The aim of this study was to develop a PPF for estimating the likelihood of post-surgical
improvement in patients with lumbar spinal stenosis at one year follow-up, conditional on a
set of prognostic indicators measured at baseline.
Materials and methods
The Lumbar Stenosis Outcome Study (LSOS) is a prospective cohort study investigating the
effectiveness of various treatment options in patients with symptomatic lumbar spinal stenosis
[10]. Participation in the study had no influence on the treatment of the patients, all treatment
decisions were left to the patient and physician. 841 patients were recruited from December
2010 to December 2015, and were followed-up for three years.
The present study is reported according to STROBE (Statement for reporting cohort stud-
ies) guidelines [11] and TRIPOD (Statement for studies reporting clinical prediction models)
guidelines [12] (S1 and S2 Files).
Inclusion and exclusion criteria
The following characteristics were required for study eligibility: age�50 years, uni- or bilateral
neurogenic claudication, verified stenosis of the lumbar spinal canal determined by magnetic
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resonance imaging (MRI), life expectancy�1 year, ability to give informed consent, availabil-
ity for follow-up, and ability to complete questionnaires in the German language. We excluded
patients with cauda equina syndrome requiring urgent surgery, current fracture, infection, sig-
nificant deformity (>15˚ lumbar scoliosis) of the lumbar spine, current enrollment in another
spine-related treatment study, and clinically relevant peripheral arterial disease (as confirmed
by a vascular specialist in patients without palpable lower limb pulse).
Eligibility criteria for inclusion in the analysis
All patients who underwent surgery within six months of enrollment and with 12 months of
follow-up data were included in the analysis.
Surgical procedures and radiological classification
The surgery consisted of a standard open posterior lumbar laminotomy with or without
instrumentation of the affected level(s). The surgeon’s discretion determined the decision to
proceed with a laminotomy using unilateral technique, to decompress the contralateral recess,
or to take a midline approach with bilateral laminotomy. Fusion surgery included implanta-
tion of pedicle screws with rods, plus intersomatic fusion and cage(s) at the affected level(s), in
addition to decompression surgery. Additional fusion, single or multi-level decompression, or
the use of an operating microscope was based on the surgeon’s discretion. The procedures
were done or supervised by senior neuro- or orthopedic surgeons with more than ten years of
experience after board-certification, and each patient’s MRI was independently evaluated by
two senior radiologists.
Data collection and follow-up
Baseline data was taken from interviews and recorded by a study coordinator. All other ques-
tionnaires were self-administered by the patients themselves. Data were collected at baseline
and after 12 months.
Outcome measures
Spinal Stenosis Measure (SSM): The SSM is an instrument specifically developed and validated
for spinal stenosis patients by Stucki and colleagues [13], and both measures symptom severity
and quantifies disability in patients with lumbar spinal stenosis. The SSM is recommended by
the North American Spine Society (NASS) and is used in many different studies of lumbar spi-
nal stenosis [14–17]. Scores range from 1–5 and 1–4 (best-worst) for SSM symptoms score and
SSM function score. A minimal clinically important difference (MCID) in SSM symptoms
score is defined by an improvement of 0.48 points from baseline to 12 months, and an
improvement of 0.52 defines an MCID in SSM function score [18].
Development of a PPF and choice of prognostic indicators
A PPF derives the probability of a future event based on a set of prognostic indicators defined
at a specified point in time [19]. In this application, the future event was MCID one year after
baseline in SSM symptoms score or SSM function score. We studied the literature to generate
a list of prognostic indicators [20–23]. The dichotomous and continuous parameters measured
at baseline and available in the LSOS database were included in the PROCESS (PostopeRative
OutComE Spinal Stenosis) PPF. The list of prognostic indicators is summarized in Table 1.
Prognostic probability function for patients with lumbar spinal stenosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0207126 November 8, 2018 3 / 15
Patient scenarios
The PPF’s usability in terms of pain and disability was also assessed by characterizing two sce-
narios, one with a very favorable constellation of prognostic indicators, and the second with a
disadvantageous constellation of prognostic indicators. We calculated the estimated probabili-
ties of MCID in these two scenarios.
Scenario 1 (favorable). Male patient, all favorable prognostic indicators present (Table 1),
age<75 years, BMI<30 kg/m2, non-smoking, not living alone or single/divorced/widowed
and living in a nursing/residential home, no low education, no cox- or gonarthrosis, coronary
heart disease or heart insufficiency, no asthma or chronic obstructive pulmonary disease
(COPD), no Parkinson’s disease or peripheral neuropathy, able to walk more than 200 m, no
low back pain, duration of symptoms <6 months, analgesic use within 3 months before base-
line, no previous lumbar surgery, surgery on one single lumbar spinal level, narrowing of the
cross sectional area (�70 mm2) or the diameter of the dural sac (�6 mm), no depression, aver-
age quality of life score of 50 points, baseline SSM symptoms and function scores both 3.5.
Scenario 2 (unfavorable). Female patient, all favorable prognostic indicators absent (Table 1),
average quality of life score of 50, baseline SSM symptoms and function scores both 2.
Table 1. List of 21 prognostic indicators used in the prognostic probability function for meaningful clinically
important difference (MCID) in SSM symptoms score and SSM function score one year after baseline.
Prognostic indicator
Dichotomous Unfavorable
Age �75 years [21]
Gender female
BMI �30 kg/m2 [24]
Current smoker yes
Civil status living alone, or single/divorced/widowed and living in a nursing/
residential home
Formal education compulsory school only
Coxarthrosis or gonarthrosis yes
Coronary heart disease or heart insufficiency yes
Asthma or COPD yes
Parkinson’s disease or peripheral neuropathy yes
Walking ability being able to walk only up to 200 m
Low back pain yes
Duration of symptoms �6 months [25]
Preoperative analgesic use within 3 months
before baseline
yes
Previous lumbar surgery yes
Number of decompressed levels >1 level
Radiological parameters Antero-posterior diameter of dural sac (APD) >6 mm or cross
sectional area >70 mm2 [22]
Depression (on HADS depression scale) �8 points [26]
Continuous Range
Quality of life (EQ5D-3L scale) 0 (worst)– 100 (best)
Baseline SSM symptoms score 1 (best)– 5 (worst)
Baseline SSM function score 1 (best)– 4 (worst)
BMI = body mass index; COPD = chronic obstructive pulmonary disease; HADS = Hospital Anxiety and Depression
Scale; SSM = Spinal Stenosis Measure
https://doi.org/10.1371/journal.pone.0207126.t001
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Statistical methods
Thorough development and validation of a PPF is important [27]. For that reason, patients were
randomly split once into a derivation subsample (2/3 of the patients) for development of the PPF
and a validation subsample (1/3 of the patients) for validation of the function, in order to determine
the validity of results for new patients [28]. Descriptive statistics included median and interquartile
ranges for continuous variables, and counts and percentages of total for categorical variables. Cor-
responding Wilcoxon and chi-squared tests were used to compare the two subsamples.
There was missing data for some of the patients for some of the prognostic indicators.
These were filled using 10-fold multiple imputation based on chained equations [29], retaining
the information about the derivation and validation subsamples.
The two binary outcome variables, MCID in SSM symptoms and SSM function were
addressed with logistic regression models fitted to each outcome in each of the ten imputed
derivation subsamples including all 21 prognostic indicators.
PPF models with a large number of prognostic indicators tend to describe optimally the
data under study, but predictions for new subjects will perform less well. To address this phe-
nomenon, called overfitting, the regression coefficients of the PPF can be shrinked towards
zero by multiplying with a global shrinkage factor. E.g., a coefficient of 0.8 becomes 0.72 (=
0.8�0.9) if the shrinkage factor was 0.9. We derived a global shrinkage factor for the estimated
regression coefficients using the dfbeta-method [30]. A global shrinkage factor for the model
addressing MCID in SSM symptoms and a global shrinkage factor for MCID in SSM function
was calculated in each of the ten imputed derivation subsamples and then averaged, resulting
in one global shrinkage factor for each outcome.
Pooled regression coefficients were calculated from the ten derivation subsamples following
Rubin’s rule [31], and the two global shrinkage factors were applied. Original and shrunken
regression coefficients are summarized as odds ratios with 95% confidence intervals (CI). The
pooled and shrunken regression coefficients were applied to each of the ten multiply imputed
validation subsamples, resulting in predictions of the probability for MCID in SSM symptoms
and SSM function scores.
After the derivation of a PPF, one would like to know how well the predicted probability for
MCID (continuous between 0 and 1) corresponds to the actual observed MCID-status (0 or 1)
in SSM symptoms and SSM function. This can be measured with the discriminative ability of
the PPF, as well as with its calibration. A receiver operating characteristic (ROC) plot displays
the true positive rate against the false positive rate for consecutive cut-offs for the predicted
probability. The area under this ROC curve (AUC) with 95% CI is calculated to assess the dis-
criminative ability of the PPF. Calibration is another important property of a probability func-
tion, and it measures the agreement between observed outcomes and predictions. We used
calibration plots, for 10-fold imputed derivation and validation subsamples.
All analyses were conducted using R for Windows [32], using the packages dplyr, MASS,
mice, mitools, openxlsx, PresenceAbsence, pROC, rms, rpart, shrink, and tableone. Our work
was conducted following the concept of reproducible research and the R-code is available
upon request [33].
Sample size
The sample size was calculated for the development of a PPF for patients undergoing spine
surgery, one year after surgery [10]. For sample size calculation, we anticipated that 60% of the
included 841 patients (= 505 patients) with verified diagnosis would undergo surgery. Actually,
543 patients underwent surgery during the follow-up, 498 of these within the first six months
after baseline and 452 of these had a follow-up of at least 12 months.
Prognostic probability function for patients with lumbar spinal stenosis
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We anticipated that two thirds of the patients would show a clinically relevant improvement
one year after surgery. Based these assumptions, the number of prognostic indicators in the logistic
regression model in the derivation set may be up to 20 following the rule of 10 outcome events per
predictor variable (EPV). According to Vittinghoff and McCulloch [34], this rule can be relaxed to
5 to 9 EPVs allowing for up to 22 prognostic indicators if 9 EPVs are taken as threshold.
Ethical approval
This multi-centre cohort study was conducted in compliance with all international laws and
regulations as well as any applicable guidelines. Written informed consent to participate in the
study has been obtained from participants. The study was approved by the independent Ethics
Committee of the Canton Zurich (KEK-ZH-NR: 2010-0395/0).
Results
Patient characteristics
Four hundred and fifty-two patients who received surgery for lumbar spinal stenosis within
six months of baseline had 12-month follow-up data (Fig 1). 300 were randomly selected for
Fig 1. Patient flow chart.
https://doi.org/10.1371/journal.pone.0207126.g001
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the derivation subsample, and the remaining 152 patients were allocated to the validation sub-
sample. 141 patients in the derivation subsample (47%) were 75 years or older, while 73 (48%)
of patients in the validation subsample were in the same age range. 51% and 52%, respectively,
were female. Details for all prognostic indicators are shown in Table 2. There were no differ-
ences between the subsamples across all variables.
MCID in SSM symptoms and SSM function scores
73% of the patients in the derivation subsample and 70% of patients in the validation subsam-
ple reached an MCID in SSM symptoms score after surgery. The percentages for MCID in
SSM function score were 68% and 63%, respectively.
Intra- and postoperative complications
Eighteen (6.0%) patients of the derivation subsample suffered an injury of the dura during sur-
gery, the corresponding numbers were 9 (5.9%) in the validation subsample. No patient in the
derivation subsample and three patients (2.0%) in the validation subsample experienced epidu-
ral venous bleeding.
In the derivation subsample, 5 (1.7%) patients had a wound infection, other complications
(e.g., urosepsis, hemorrhage, wound healing deficit) were experienced by 25 (8.3%) patients.
In the validation subsample, no wound infections were observed, and 15 (9.9%) patients had
other complications. Twenty-two (7.3%) patients had a reoperation in the derivation subsam-
ple and 15 (9.9%) patients in the validation subsample.
Table 2. Preoperative baseline characteristics.
Derivation
data set
Validation
data set
p-value
N = 300 N = 152
Age�75 years, No. (%) 141 (47.0) 73 (48.0) 0.915
Female gender, No. (%) 152 (50.7) 79 (52.0) 0.870
BMI�30 kg/m2, No. (%) 83 (27.7) 47 (30.9) 0.540
Current smoker, No. (%) 50 (16.7) 24 (15.9) 0.929
Living alone, or single/divorced/widowed and living in nursing home, No. (%) 95 (31.7) 56 (36.8) 0.319
Compulsory school only, No. (%) 70 (23.5) 45 (29.6) 0.196
Coxarthrosis or gonarthrosis, No. (%) 105 (38.0) 54 (36.7) 0.873
Coronary heart disease or heart insufficiency, No. (%) 19 (6.9) 10 (6.8) 1
Asthma or COPD, No. (%) 28 (10.0) 19 (12.8) 0.465
Parkinson’s disease or peripheral neuropathy, No. (%) 7 (2.5) 6 (4.1) 0.552
Being able to walk only up to 200m, No. (%) 209 (69.9) 99 (65.1) 0.357
Low back pain, No. (%) 263 (88.0) 133 (88.1) 1
Duration of symptoms�6 months, No. (%) 182 (61.1) 87 (58.0) 0.600
Preoperative analgesic use within 3 months before baseline, No. (%) 242 (80.9) 117 (78.5) 0.633
Previous lumbar surgery, No. (%) 27 (9.0) 22 (14.5) 0.108
More than one decompressed level, No. (%) 181 (60.5) 82 (55.8) 0.392
Diameter of the dural sac (APD) >6 mm or cross sectional area >70 mm2 (%), No. (%) 52 (17.3) 34 (22.4) 0.245
Depression on HADS scale�8, No. (%) 56 (18.7) 26 (17.2) 0.793
Quality of life on EQ5D actual health status, median [IQR] 64.0 [40.0, 80.0] 63.5 [40.0, 80.0] 0.818
Baseline SSM symptoms score, median [IQR] 3.1 [2.7, 3.6] 3.1 [2.9, 3.5] 0.912
Baseline SSM function score, median [IQR] 2.2 [1.8, 2.8] 2.2 [1.8, 2.8] 0.808
BMI = body mass index; COPD = chronic obstructive pulmonary disease; HADS = Hospital Anxiety and Depression Scale; SSM = Spinal Stenosis Measure
https://doi.org/10.1371/journal.pone.0207126.t002
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Multiple imputation and shrinkage factors
There were missing values for 18 of the prognostic indicators. The percentage of missing val-
ues varied between 0.2% in walking ability, and 6.4% for the coxarthrosis/gonarthrosis vari-
able. Ten-fold multiple imputation was applied.
The continuous prognostic indicators baseline SSM symptoms score and SSM function
score, and EQ-5D actual health status were entered in a linear as well as in a quadratic fashion
and the residual plot was in favor of the linear effect for all three of them.
The resulting average global shrinkage factors were 0.47 for MCID in SSM symptoms score
and 0.60 for MCID in SSM function score.
Pooled regression coefficients expressed as log odds ratios and 95% CIs are summarized in
Table 3 (MCID in SSM symptoms score as outcome) and Table 4 (MCID in SSM function
score as outcome). The shrinked regression coefficients are also displayed for each outcome.
These were the final coefficients, and were used for calculating the probability of MCID in
SSM symptoms score and SSM function score following surgery.
Discriminative ability of PROCESS, calibration and validation
In the derivation subsample, the discriminative ability as measured with the AUC of the PPF
was 0.64 (95% CI 0.57 to 0.71) for the MCID in SSM symptoms score after shrinkage. The
AUC was 0.62 (0.52 to 0.72) in the validation subsample. The corresponding values were 0.71
Table 3. PROCESS: Estimated coefficients and their 95% confidence intervals, p-values, and shrinked coefficients for the SSM symptoms score. The shrinkage factor
was 0.47.
MCID in SSM symptoms Coefficients = log odds
ratios
Lower bound of
95% CI
Upper bound of
95% CI
p-value Shrinked
coefficients
(Intercept) -1.212 -3.878 1.455 0.372 -0.565
Age -0.460 -1.090 0.171 0.152 -0.214
Gender 0.108 -0.568 0.785 0.753 0.050
Body mass index -0.443 -1.118 0.232 0.197 -0.207
Current smoker -0.021 -0.853 0.811 0.960 -0.010
Civil status -0.178 -0.874 0.519 0.616 -0.083
Formal education -0.232 -0.924 0.460 0.510 -0.108
Coxarthrosis or gonarthrosis -0.399 -1.041 0.243 0.221 -0.186
Coronary heart disease or heart insufficiency -1.221 -2.348 -0.093 0.034 -0.569
Asthma or COPD 0.612 -0.609 1.833 0.324 0.285
Parkinson’s disease or peripheral neuropathy -1.218 -3.115 0.679 0.206 -0.568
Walking ability -0.189 -0.939 0.561 0.621 -0.088
Low back pain -0.439 -1.405 0.528 0.372 -0.205
Duration of symptoms 0.004 -0.618 0.626 0.990 0.002
Preoperative analgesic use within 3 months before baseline -0.070 -0.864 0.724 0.862 -0.033
Previous lumbar surgery 0.050 -0.958 1.057 0.923 0.023
Number of decompressed levels -0.269 -0.882 0.344 0.389 -0.125
Antero-posterior diameter of dural sac (APD) >6 mm or cross
sectional area >70 mm2
-0.694 -1.421 0.032 0.061 -0.324
Depression (on HADS depression scale) -1.091 -1.872 -0.311 0.006 -0.509
Quality of life (EQ5D-3L scale) 0.001 -0.013 0.015 0.882 0
Baseline SSM symptoms score 1.396 0.761 2.032 <0.001 0.652
Baseline SSM function score -0.174 -0.808 0.460 0.589 -0.081
CI = confidence interval; COPD = chronic obstructive pulmonary disease; HADS = Hospital Anxiety and Depression Scale; SSM = Spinal Stenosis Measure
https://doi.org/10.1371/journal.pone.0207126.t003
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(0.64 to 0.77) in the derivation subsample and 0.70 (0.60 to 0.79) in the validation subsample
for the MCID in SSM function score.
The corresponding ROC curves are displayed in Fig 2 by applying the PPF with shrinked
coefficients to the ten derivation (black lines) and the ten validation (grey lines) subsamples
resulting from the multiple imputation. The left panel shows the MCID in SSM symptoms
score, and the right panel shows MCID in SSM function score.
The calibration plots in Fig 3 show that there was good overall calibration of the PPFs when
probabilities for MCID were displayed against bins of observed probabilities for MCID. The
upper panels show results for SSM symptoms score, and the lower panels show results for SSM
function score.
The information whether fusion was added or not to decompression surgery was entered as
an additional variable to the PPF. The resulting AUC of the PPF in the derivation subsample
was 0.64 (95% CI 0.57 to 0.71) for the MCID in SSM symptoms score after shrinkage and 0.62
(0.52 to 0.72) in the validation subsample. The corresponding values for the MCID in SSM
function score were 0.71 (0.64 to 0.77) and 0.68 (0.59 to 0.77).
Specific patient scenarios
The estimated probability for MCID after surgery in SSM symptoms score was 81% in the
favorable scenario (Scenario 1), and 9% in the unfavorable scenario (Scenario 2). For the
Table 4. PROCESS: Estimated coefficients and their 95% confidence intervals, p-values, and shrinked coefficients for the SSM function score. The shrinkage factor
was 0.60.
MCID in SSM function Coefficients = log odds
ratios
Lower bound of
95% CI
Upper bound of
95% CI
p-value Shrinked
coefficients
(Intercept) -1.054 -3.692 1.584 0.432 -0.633
Age -0.603 -1.233 0.028 0.061 -0.362
Gender -0.002 -0.670 0.665 0.994 -0.001
Body mass index -0.957 -1.634 -0.281 0.006 -0.574
Current smoker 0.467 -0.370 1.304 0.273 0.280
Civil status 0.592 -0.133 1.316 0.109 0.355
Formal education 0.113 -0.607 0.834 0.757 0.068
Coxarthrosis or gonarthrosis -0.711 -1.364 -0.058 0.033 -0.427
Coronary heart disease or heart insufficiency -0.742 -1.834 0.351 0.182 -0.445
Asthma or COPD -0.722 -1.769 0.326 0.176 -0.433
Parkinson’s disease or peripheral neuropathy -1.103 -2.930 0.725 0.234 -0.662
Walking ability 0.108 -0.676 0.892 0.786 0.065
Low back pain -1.127 -2.111 -0.142 0.025 -0.676
Duration of symptoms -0.046 -0.672 0.580 0.885 -0.028
Preoperative analgesic use within 3 months before baseline -0.366 -1.168 0.435 0.369 -0.220
Previous lumbar surgery -0.987 -1.951 -0.022 0.045 -0.592
Number of decompressed levels -0.377 -1.001 0.247 0.235 -0.226
Antero-posterior diameter of dural sac (APD) >6 mm or cross
sectional area >70 mm2
-0.571 -1.322 0.180 0.136 -0.343
Depression (on HADS depression scale) -0.552 -1.350 0.247 0.175 -0.331
Quality of life (EQ5D-3L scale) 0.010 -0.004 0.025 0.169 0.006
Baseline SSM symptoms score -0.239 -0.834 0.357 0.431 -0.143
Baseline SSM function score 2.038 1.312 2.764 <0.001 1.223
CI = confidence interval; COPD = chronic obstructive pulmonary disease; HADS = Hospital Anxiety and Depression Scale; SSM = Spinal Stenosis Measure
https://doi.org/10.1371/journal.pone.0207126.t004
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MCID in SSM function score, the first scenario resulted in an estimated probability of success
of 97%, while it was only 6% in the second scenario.
We demonstrate how these two scenarios lead to the aforementioned probabilities in S1
and S2 Tables. The probabilities of every other constellation of prognostic indicators can be
calculated online at www.evimed.ch/PROCESS.
Discussion
We derived and validated PROCESS in a population of 452 patients with lumbar spinal steno-
sis in order to estimate the probability of reaching a minimal clinically important difference
(MCID) one year after baseline. The discriminative ability and calibration of the PPF for
MCID in SSM function score was better than that for SSM symptoms score. Approximately
two thirds of the patients benefitted from spinal surgery, however, preoperative prognostic
indicators had a large impact on individual outcomes. High baseline pain or functional
impairment levels were among the strongest indicators positively associated with MCID in
symptoms or function. Depression, low back pain, and previous lumbar surgery were nega-
tively associated. Estimated probabilities of MCID varied, and ranged from 6% to 97%.
The authors of current treatment guidelines identified limited evidence to recommend sur-
gical treatment for patients with lumbar spinal stenosis [35], and did not address the impor-
tance of prognostic indicators in the treatment decision. Several prognostic indicators
associated with clinically meaningful improvement were identified in a systematic review.
These included better reported walking capacity, better self-rated health, and shorter symptom
duration [22]. Indicators for an unfavorable outcome after surgery were cardiovascular comor-
bidity, low back pain, and higher outcome expectations [22]. The majority of the original stud-
ies included in the systematic review were of “low quality” and based on small patient samples,
likely leading to overly simplified prediction models based on a single or a few prognostic indi-
cators. More recently, several studies identified that a higher degree of baseline disability is
Fig 2. Receiver operating characteristic curves for MCID in SSM symptoms score and SSM function score. � Black lines
show results from ten imputed derivation subsamples, grey lines show results from ten imputed validation subsamples. The
discriminative ability of the PPF was 0.64 (derivation = black lines) and 0.62 (validation = grey lines) for SSM symptoms
score (left panel). The corresponding values were 0.71 and 0.70 for SSM function score as outcome (right panel).
MCID = meaningful clinically important difference; SSM = Spinal Stenosis Measure.
https://doi.org/10.1371/journal.pone.0207126.g002
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associated with increased improvement of functional outcome [20, 36–38], while smoking [36,
39, 40] and psychiatric disease [20, 41] were associated with an unfavorable outcome. Athivira-
ham et al.[20] reported that higher BMI was associated with less functional improvement,
while Pearson et al. [36] reported no difference in function between patients with BMI greater
Fig 3. Calibration plots of observed versus predicted probabilities for MCID in SSM symptoms score and SSM function score. The left panel shows
results from the derivation subsample, and the right panel shows results from the validation subsample. Overall, there was good calibration of the PPF
when probabilities for MCID were displayed against bins of observed probabilities for MCID, shown in upper panels for SSM symptoms score and lower
panels for SSM function score. MCID = meaningful clinically important difference; SSM = Spinal Stenosis Measure; MI = multiple imputation.
https://doi.org/10.1371/journal.pone.0207126.g003
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than or equal to 30 and those with a BMI below 30. A few recently published studies consid-
ered only a limited patient sample [20, 21, 37, 38] and did not investigate the influence of the
indicators on established clinically meaningful improvement [20, 37, 38].
In PROCESS, all available prognostic indicators previously identified were simultaneously
included. Given the serious problem of overfitting in the development of PPFs in a large data-
base, we deliberately refrained from an additional selection of parameters collected in the
LSOS database, as this would have resulted in optimism regarding the model’s predictive per-
formance in new patients [42]. To address optimism in PROCESS, shrinkage was applied to
the regression coefficients and the final models were validated in a random sample of one
third of patients previously withheld from the analysis.
The discriminative ability of PROCESS was not altered by the inclusion of the information
whether fusion was added or not to decompression surgery.
This study has several strengths. The data were collected prospectively in multiple study
centers, and the disease-specific questionnaires SSM symptoms score and SSM function score
were used to measure pain and disability. We also applied advanced methodology to obtain a
robust PPF using multiple imputation techniques and shrinkage. The performance of the PPF
was measured with an unused validation portion of the data set.
A weakness of our study is the fact that the prognostic indicators “coronary heart disease or
cardiac insufficiency”, “asthma or COPD”, and “Parkinson’s disease or peripheral neuropathy”
happened to have a low prevalence in our data set. Another weakness is that not all risk factors
published by Aalto et al. [21, 22] and Athiviraham et al. [20] were collected in the LSOS study:
we had no information on preoperative scoliosis (an exclusion criterion in our study when
>15˚), income, or outcome expectations.
Our method provided clinicians with individualized estimates of success probability with
respect to pain and functional improvement that was both easy to understand and simple to
communicate to the patient.
Surgical treatment for patients with lumbar spinal stenosis is being performed with increas-
ing frequency [43], leading to higher costs for the health care system. PROCESS is conditional
on the individual pattern of preoperatively available prognostic indicators, and may be helpful
for clinicians in counselling patients and in guiding the discussion on individual treatment
decision in the era of personalized medicine.
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